NEW PEPTIDYL-ANTHRAQUINONES : SYNTHESIS AND DNA BINDING

Abstract Aminoacyl-hydroxy-anthraquinones bearing glicyl, varyl, lysyl and tryptophanyl residues in the side-chain were synthesized as new potential DNA-directed drugs. These compounds bind very tightly to double-stranded DNA by intercalating their planar portion into the nucleic acid and further stabilizing the complex through electrostatic contacts with the backbone phosphates. All protonated groups in the side-chains participate in the latter process. The free energy of DNA-binding corrected for the electrostatic contribution is similar for the lysyl and glicyl derivatives, which points to a common geometry of intercalation.

[1]  E. Uriarte,et al.  Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. , 1996, Journal of medicinal chemistry.

[2]  J. S. Macpherson,et al.  Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs. , 1995, Anti-cancer drug design.

[3]  R. Gebhardt,et al.  Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates. , 1993, Cancer research.

[4]  C. Fournier,et al.  Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His. , 1993, Journal of Medicinal Chemistry.

[5]  D. Faulds,et al.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. , 1991, Drugs.

[6]  J. Hénichart,et al.  Free radical production and DNA cleavage by copper chelating peptide-anthraquinones. , 1990, Anti-cancer drug design.

[7]  J. R. Brown,et al.  Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents. , 1990, Free radical research communications.

[8]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[9]  J. R. Brown,et al.  Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone. , 1989, Free radical research communications.

[10]  J. Lown,,et al.  Anthracycline and anthracenedione-based anticancer agents , 1988 .

[11]  J. Lown,,et al.  Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone. , 1988, Free radical biology & medicine.

[12]  T. Lohman,et al.  Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity , 1978, Quarterly Reviews of Biophysics.

[13]  G. S. Manning.  The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.

[14]  D. Seyferth.  Houben-Weyl methoden der organischen chemie , 1978 .

[15]  P. V. von Hippel,et al.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. , 1974, Journal of molecular biology.